Critical Low Serum Magnesium Threshold
The critically low serum magnesium concentration is <0.85 mmol/L (2.07 mg/dL, 1.70 mEq/L), below which there is increased risk of chronic disease including type 2 diabetes and cardiovascular disease.
Evidence-Based Threshold
The current standard laboratory reference ranges (typically 0.75-0.95 mmol/L) are outdated and based on population distributions from NHANES I (1971-1974) rather than clinical outcomes 1. Expert consensus now supports 0.85 mmol/L as the evidence-based lower limit because levels below this threshold are associated with increased disease risk 2.
Recent population data from NHANES 2021-2023 establishes contemporary reference intervals 3:
- Metabolically healthy adults: 1.72-2.26 mg/dL (0.71-0.93 mmol/L) for males and 1.70-2.21 mg/dL (0.70-0.91 mmol/L) for females
- Using the <2.06 mg/dL (<0.85 mmol/L) threshold, 67.8% of US adults have chronic latent magnesium deficiency (CLMD)
Clinical Context by Population
Adults with Metabolic Disease
Mean serum magnesium is significantly lower in patients with 3:
- Diabetes: Most pronounced reduction (P<0.001)
- Hypertension: Moderate reduction (P=0.012-0.029)
- Chronic kidney disease: Significant reduction (P=0.002-0.007)
Critically Ill Patients
In intensive care settings, a critical threshold of 0.58 mg/dL (0.24 mmol/L) was identified as prognostic of metabolic disturbances leading to grave clinical status 4. However, this represents severe acute depletion rather than the chronic deficiency threshold.
Important Caveats
Serum magnesium is a poor biomarker because it contains <1% of total body magnesium and is homeostatically defended through renal reabsorption and bone exchange 5. Individuals with substantial tissue depletion may present with normal serum values. The reference change value is only ~12%, making detection of deficiency difficult 5.
For ionized magnesium (iMg2+), the reference range for healthy adults is 0.40-0.68 mmol/L, though this overlaps substantially with disease states 6.
Clinical Algorithm
- Screen high-risk populations (diabetes, hypertension, CKD, diuretic use, GI malabsorption)
- Flag values <0.85 mmol/L (2.07 mg/dL) as indicating increased chronic disease risk, even if within laboratory "normal" range
- Consider supplementation when <0.85 mmol/L, particularly in hypertensive patients (BP reduction of -7.68/-2.96 mmHg) 7 or those with documented hypomagnesemia (BP reduction of -5.97/-4.75 mmHg) 7
- Recognize that normal serum levels do not exclude tissue deficiency - clinical context and dietary intake assessment remain essential 5